Cancer Clinical Epidemiology Training Grant
Cancer Clinical Epidemiology Training Grant
批准号:
10555799
负责人:
Richard Aplenc
金额:
$52.4万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
未结题
起止时间:
1992-09-01 至 2028-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The Department of Biostatistics, Epidemiology and Informatics (DBEI) and the Abramson Cancer Center
(ACC), in collaboration with the Division of Hematology-Oncology of the Department of Medicine and the
Division of Oncology of the Department of Pediatrics, all at the University of Pennsylvania Perelman School of
Medicine (PSOM), propose to continue an innovative, rigorous, and successful training program for
investigators in cancer clinical epidemiology. Five postdoctoral positions per year are requested.
This training program attracts trainees from across the country; its graduates are placed in institutions
nationwide, resulting in a high impact training program. The specific aims of the training program are to: 1)
train the next generation of investigators to address novel and critical cancer epidemiology questions with
innovative analytic methods and transdisciplinary research collaborations; 2) provide in-depth knowledge of
clinical epidemiology research methods for research questions across the cancer care continuum and lifespan;
3) provide intensive, supervised research experience resulting in first-authored publications with mentors who
have active research programs in pediatric and adult cancer; and 4) promote synergies between epidemiology
trainees and investigators outside of epidemiology through seminars and workshops offered at DBEI, the ACC,
the pediatric and adult clinical oncology divisions, and other research centers at Penn and CHOP.
Didactic training is provided through the Master of Science in Clinical Epidemiology (MSCE) program and
the directors of the training program receive regular feedback to optimize the progress of each fellow. The
principal concepts of rigorous research are taught in courses of fundamental epidemiological methods, cancer
and molecular epidemiology, and biostatistics, elective courses relevant to the trainees’ methodologic interests;
journal clubs and clinical research conferences conducted by participating faculty, the DBEI, ACC, and adult
and pediatric oncology divisions; independent readings; and instruction in the responsible conduct of research.
Strengths of the proposed program are: 1) the history of successful research training programs in the DBEI,
ACC, and adult and pediatric oncology divisions, including this training program; 2) the collaborative links
among faculty with interests in clinical research in cancer; 3) the comprehensive course offerings and research
programs that are available to trainees; and 4) an extensive set of experienced faculty with successful training
records. In addition, numerous existing large databases that can be used for research projects and training; a
broad array of specialized analytic capabilities available for clinical studies employing methods of clinical
epidemiology, and commitment of faculty to collaborative research and training, combine to provide an ideal
environment for this training program. Finally, the PSOM promote an academic environment in which basic and
clinical research are encouraged and viewed as attractive career paths for physicians.
期刊论文(61)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/phar.2463
发表时间:
2020-11
期刊:
Pharmacotherapy
影响因子:
4.1
作者:
[Varughese LA, Lau-Min KS, Cambareri C, Damjanov N, Massa R, Reddy N, Oyer R, Teitelbaum U, Tuteja S]
通讯作者:
Tuteja S
Screening for colon cancer: a review of current and future strategies.
结肠癌筛查:当前和未来策略的回顾。
DOI:
--
发表时间:
1995
期刊:
Seminars in oncology.
影响因子:
--
作者:
[Weinberg,DS, Strom,BL]
通讯作者:
Strom,BL
Determinants of the optimal first-line therapy for follicular lymphoma: a decision analysis.
滤泡性淋巴瘤最佳一线治疗的决定因素:决策分析。
DOI:
10.1002/ajh.21655
发表时间:
2010
期刊:
American journal of hematology
影响因子:
12.8
作者:
[Olin,RebeccaL, Kanetsky,PeterA, TenHave,ThomasR, Nasta,SunitaD, Schuster,StephenJ, Andreadis,Charalambos]
通讯作者:
Andreadis,Charalambos
Treatment and Outcomes of Oropharyngeal Cancer in People with Human Immunodeficiency Virus.
人类免疫缺陷病毒感染者口咽癌的治疗和结果。
DOI:
10.1089/aid.2019.0009
发表时间:
2019
期刊:
AIDS research and human retroviruses
影响因子:
1.5
作者:
[Brickman,CristinaE, Propert,KathleenJ, Merlin,JessicaS, Liu,JeffreyC, Eady,Sequoya, Mcghee-Jez,Amy, Ragin,Camille, Grover,Surbhi, Cohen,RogerB, Gross,Robert]
通讯作者:
Gross,Robert
Microsphere-Based Assessment of DNA Methylation for AML Prognosis.
基于微球的 DNA 甲基化评估对 AML 预后的影响。
DOI:
10.1007/978-1-4939-7142-8_8
发表时间:
2017
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
[Wertheim,GeraldBW, Luskin,MarliseR, Carroll,Martin, Master,StephenR]
通讯作者:
Master,StephenR
共 37 条
Predicting and Monitoring for Cardiac Toxicity in Pediatric AML
-
批准号:10659987
-
项目类别:
-
资助金额:$81.94万
-
财政年份:2023
-
负责人:Richard Aplenc
-
依托单位:
COG NCTN Network Group Operations Center
-
批准号:10230669
-
项目类别:
-
资助金额:$270.2万
-
财政年份:2014
-
负责人:Richard Aplenc
-
依托单位:
COG NCTN Network Group Operations Center
-
批准号:10221076
-
项目类别:
-
资助金额:$3.15万
-
财政年份:2014
-
负责人:Richard Aplenc
-
依托单位:
Toxicity Monitoring on Phase III Trials with Administrative Data
-
批准号:8843803
-
项目类别:
-
资助金额:$41.03万
-
财政年份:2012
-
负责人:Richard Aplenc
-
依托单位:
Toxicity Monitoring on Phase III Trials with Administrative Data
-
批准号:8519978
-
项目类别:
-
资助金额:$46.16万
-
财政年份:2012
-
负责人:Richard Aplenc
-
依托单位:
Toxicity Monitoring on Phase III Trials with Administrative Data
-
批准号:8676741
-
项目类别:
-
资助金额:$39.78万
-
财政年份:2012
-
负责人:Richard Aplenc
-
依托单位:
Toxicity Monitoring on Phase III Trials with Administrative Data
-
批准号:8370273
-
项目类别:
-
资助金额:$49.51万
-
财政年份:2012
-
负责人:Richard Aplenc
-
依托单位:
Genetic Predictors of AML Treatment Response
-
批准号:8042588
-
项目类别:
-
资助金额:$57.27万
-
财政年份:2010
-
负责人:Richard Aplenc
-
依托单位:
Genetic Predictors of AML Treatment Response
-
批准号:8209299
-
项目类别:
-
资助金额:$56.09万
-
财政年份:2010
-
负责人:Richard Aplenc
-
依托单位:
Genetic Predictors of AML Treatment Response
-
批准号:7792497
-
项目类别:
-
资助金额:$67.41万
-
财政年份:2010
-
负责人:Richard Aplenc
-
依托单位:
Genetic Predictors of AML Treatment Response
-
批准号:8403622
-
项目类别:
-
资助金额:$52.26万
-
财政年份:2010
-
负责人:Richard Aplenc
-
依托单位:
GENETIC PREDICTORS OF LEUKEMIA THERAPY RESPONSE
-
批准号:7616583
-
项目类别:
-
资助金额:$25.62万
-
财政年份:2005
-
负责人:Richard Aplenc
-
依托单位:
GENETIC PREDICTORS OF LEUKEMIA THERAPY RESPONSE
-
批准号:6920478
-
项目类别:
-
资助金额:$30.21万
-
财政年份:2005
-
负责人:Richard Aplenc
-
依托单位:
GENETIC PREDICTORS OF LEUKEMIA THERAPY RESPONSE
-
批准号:7263917
-
项目类别:
-
资助金额:$25.69万
-
财政年份:2005
-
负责人:Richard Aplenc
-
依托单位:
GENETIC PREDICTORS OF LEUKEMIA THERAPY RESPONSE
-
批准号:7407356
-
项目类别:
-
资助金额:$25.55万
-
财政年份:2005
-
负责人:Richard Aplenc
-
依托单位:
GENETIC PREDICTORS OF LEUKEMIA THERAPY RESPONSE
-
批准号:7069097
-
项目类别:
-
资助金额:$27.1万
-
财政年份:2005
-
负责人:Richard Aplenc
-
依托单位:
Cancer Clinical Epidemiology Training Grant
-
批准号:9358013
-
项目类别:
-
资助金额:$42.84万
-
财政年份:1992
-
负责人:Richard Aplenc
-
依托单位:
海外基金